Valbenatsiin
Valbenatsiin, known chemically as valbenazine, is a prescription medication used to treat tardive dyskinesia in adults. It is a selective inhibitor of vesicular monoamine transporter 2 (VMAT2), a protein that helps store and release dopamine in nerve terminals. By reducing VMAT2 activity, valbenatsiin lowers excessive dopamine release, which can lessen involuntary movements associated with long-term antipsychotic treatment.
The drug is taken by mouth and is typically prescribed as a once-daily dose, with adjustments made
Common side effects reported with valbenatsiin include somnolence, fatigue, dry mouth, and nausea. Less frequent effects